First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

por Sun, Weili, Liu, Huaying, Kim, Young, Karras, Nicole, Pawlowska, Anna, Toomey, Debbie, Kyono, Wade, Gaynon, Paul, Rosenthal, Joseph, Stein, Anthony
Publicado 2018

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world pattern...

por Barsan, Valentin, Li, Yimei, Prabhu, Snehit, Baggott, Christina, Nguyen, Khanh, Pacenta, Holly, Phillips, Christine L., Rossoff, Jenna, Stefanski, Heather, Talano, Julie-An, Moskop, Amy, Baumeister, Susanne, Verneris, Michael R., Myers, Gary Douglas, Karras, Nicole A., Cooper, Stacy, Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, Christa, Keating, Amy, Fabrizio, Vanessa, Chinnabhandar, Vasant, Kunicki, Michael, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M.
Publicado 2023

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

por Herrera, Alex F., Palmer, Joycelynne, Adhikarla, Vikram, Yamauchi, Dave, Poku, Erasmus K., Bading, James, Yazaki, Paul, Dandapani, Savita, Mei, Matthew, Chen, Robert, Cao, Thai, Karras, Nicole, McTague, Pamela, Nademanee, Auayporn, Popplewell, Leslie, Sahebi, Firoozeh, Shively, John E., Simpson, Jennifer, Smith, D. Lynne, Song, Joo, Spielberger, Ricardo, Tsai, Ni-Chun, Thomas, Sandra H., Forman, Stephen J., Colcher, David, Wu, Anna M., Wong, Jeffrey, Smith, Eileen
Publicado 2021

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

por Stefanski, Heather E., Eaton, Anne, Baggott, Christina, Rossoff, Jenna, Verneris, Michael R., Prabhu, Snehit, Pacenta, Holly L., Phillips, Christine L., Talano, Julie-An, Moskop, Amy, Margossian, Steven P., Myers, Gary Douglas, Karras, Nicole A., Brown, Patrick A., Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, M. Christa, Keating, Amy K., Wilcox, Rachel, Rabik, Cara A., Fabrizio, Vanessa A., Chinnabhandar, Vasant, Goksenin, A. Yasemin, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M.
Publicado 2022

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

por Fabrizio, Vanessa A., Phillips, Christine L., Lane, Adam, Baggott, Christina, Prabhu, Snehit, Egeler, Emily, Mavroukakis, Sharon, Pacenta, Holly, Rossoff, Jenna, Stefanski, Heather E., Talano, Julie-An, Moskop, Amy, Margossian, Steven P., Verneris, Michael R., Myers, Gary Douglas, Karras, Nicole A., Brown, Patrick A., Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, Christa, Keating, Amy K., Wilcox, Rachel, Rabik, Cara A., Chinnabhandar, Vasant, Kunicki, Michael, Goksenin, A. Yasemin, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M.
Publicado 2022

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

por Moskop, Amy, Pommert, Lauren, Baggott, Christina, Prabhu, Snehit, Pacenta, Holly L., Phillips, Christine L., Rossoff, Jenna, Stefanski, Heather E., Talano, Julie-An, Margossian, Steve P., Verneris, Michael R., Myers, G. Doug, Karras, Nicole A., Brown, Patrick A., Qayed, Muna, Hermiston, Michelle L., Satwani, Prakash, Krupski, Christa, Keating, Amy K., Wilcox, Rachel, Rabik, Cara A., Fabrizio, Vanessa A., Chinnabhandar, Vasant, Goksenin, A. Yasemin, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Guest, Erin M., Breese, Erin H., Schultz, Liora M.
Publicado 2022

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

por McNerney, Kevin O., Si Lim, Stephanie J., Ishikawa, Kyle, Dreyzin, Alexandra, Vatsayan, Anant, Chen, John J., Baggott, Christina, Prabhu, Snehit, Pacenta, Holly L., Philips, Christine, Rossoff, Jenna, Stefanski, Heather E., Talano, Julie-An, Moskop, Amy, Verneris, Michael, Myers, Doug, Karras, Nicole A., Brown, Patrick, Bonifant, Challice L., Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, Christa, Keating, Amy K., Baumeister, Susanne H. C., Fabrizio, Vanessa A., Chinnabhandar, Vasant, Egeler, Emily, Mavroukakis, Sharon, Curran, Kevin J., Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M.
Publicado 2023

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

por Fabrizio, Vanessa A., Boelens, Jaap Jan, Mauguen, Audrey, Baggott, Christina, Prabhu, Snehit, Egeler, Emily, Mavroukakis, Sharon, Pacenta, Holly, Phillips, Christine L., Rossoff, Jenna, Stefanski, Heather E., Talano, Julie-An, Moskop, Amy, Margossian, Steven P., Verneris, Michael R., Myers, Gary Douglas, Karras, Nicole A., Brown, Patrick A., Qayed, Muna, Hermiston, Michelle, Satwani, Prakash, Krupski, Christa, Keating, Amy K., Wilcox, Rachel, Rabik, Cara A., Chinnabhandar, Vasant, Kunicki, Michael, Goksenin, A. Yasemin, Mackall, Crystal L., Laetsch, Theodore W., Schultz, Liora M., Curran, Kevin J.
Publicado 2022

Mediport use as an acceptable standard for CAR T cell infusion

por Eylon, Maya, Prabhu, Snehit, John, Samuel, King, Maxwell J. M., Bhatt, Dhruv, Curran, Kevin J., Erickson, Courtney, Karras, Nicole A., Phillips, Christine L., Satwani, Prakash, Hermiston, Michelle, Southworth, Erica, Baumeister, Susanne H. C., Talano, Julie-An, MacMillan, Margaret L., Rossoff, Jenna, Bonifant, Challice L., Myers, Gary Doug, Rouce, Rayne H., Toner, Keri, Driscoll, Timothy A., Katsanis, Emmanuel, Salzberg, Dana B., Schiff, Deborah, De Oliveira, Satiro N., Capitini, Christian M., Pacenta, Holly L., Pfeiffer, Thomas, Shah, Niketa C., Huynh, Van, Skiles, Jodi L., Fraint, Ellen, McNerney, Kevin O., Quigg, Troy C., Krueger, Joerg, Ligon, John A., Fabrizio, Vanessa A., Baggott, Christina, Laetsch, Theodore W., Schultz, Liora M.
Publicado 2023